-
Company Profile
AMAG Pharmaceuticals Inc – Company Profile
AMAG Pharmaceuticals Inc (AMAG) is a pharmaceutical company focused on the development and commercialization of specialty pharmaceutical products in therapeutic areas like maternal, women's health, anemia management, and hematology. Its product portfolio includes Makena an auto-injector device, and Feraheme for intravenous. The company is developing two product pipelines; Ciraparantag is in the Phase 2b trial of healthy volunteers and AMAG-423 is in the phase 2b/3a trial. The company offers its products through a direct sales force and a network of...
Add to Basket -
Company Profile
Antares Pharma Inc – Company Profile
Antares Pharma Inc (Antares Pharma), a subsidiary of Halozyme Therapeutics Inc, is a specialty pharmaceutical company engaged in the development, manufacturing, and commercialization of pharmaceutical products and technologies. The company’s portfolio encompasses around novel therapeutic products for therapy areas related to polyarticular juvenile idiopathic arthritis, severe rheumatoid arthritis, severe recalcitrant psoriasis, migraine and cluster headache. It also develops products to reduce the risk of preterm birth in pregnant women. It caters its subcutaneous injection technology platforms to both generic and...
Add to Basket -
Product Insights
NewAntares Pharma Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Antares Pharma Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Antares Pharma Inc (Antares Pharma) is a specialty pharmaceutical company engaged in the development, manufacturing, and commercialization of pharmaceutical products and technologies. The company’s portfolio encompasses around novel therapeutic products for therapy areas related to polyarticular juvenile idiopathic arthritis, severe rheumatoid arthritis, severe recalcitrant psoriasis, migraine and cluster headache. It also develops products to reduce the risk of preterm...
-
Product Insights
Female Hypoactive Sexual Desire Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Female Hypoactive Sexual Desire Disorder pipeline market report provides a comprehensive overview of the therapeutics under development for Female Hypoactive Sexual Desire Disorder, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic...
-
Product Insights
Pre-Eclampsia Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Pre-Eclampsia Global Clinical Trials Review, H2, 2020" provides an overview of Pre-Eclampsia Clinical trials scenario. This report provides top line data relating to the clinical trials on Pre-Eclampsia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Sector Analysis
United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others
GlobalData’s “United States In Vitro Diagnostics Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on: • Annualized market...
-
Sector Analysis
North America Clinical Chemistry Market Outlook to 2025
GlobalData’s “North America Clinical Chemistry Market Outlook to 2025” is a comprehensive databook report, covering key market data on the North America Clinical Chemistry market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Substrates. The North America Clinical Chemistry Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025....
-
Sector Analysis
United States Clinical Chemistry Market Outlook to 2025
GlobalData’s “United States Clinical Chemistry Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Clinical Chemistry market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Substrates. The United States Clinical Chemistry Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025....
-
Product Insights
Pre-Eclampsia Disease – Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Pre-Eclampsia Global Clinical Trials Review, H1, 2020" provides an overview of Pre-Eclampsia Clinical trials scenario. This report provides top line data relating to the clinical trials on Pre-Eclampsia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Track & Monitor
Contract Small Molecule API Manufacturing Industry by the Numbers – 2019 PharmSource Edition
This report characterizes the contract small molecule active pharmaceutical ingredient (API) manufacturing industry through a number of quantitative dimensions, including number and type of participants, containment and controlled substance capabilities, and financial performance of the top public contract manufacturing organizations (CMOs). Contract Small Molecule API Manufacturing is critical for establishing an understanding of the small molecule API CMO industry and the features of some of the largest CMOs participating in the industry.